These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 571548)

  • 1. Cellular immune response against acetylcholine receptor in myasthenia gravis: I. Relevance to clinical course and pathogenesis.
    Conti-Tronconi BM; Morgutti M; Sghirlanzoni A; Clementi F
    Neurology; 1979 Apr; 29(4):496-501. PubMed ID: 571548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postsynapic membrane of Torpedo electroplax: acetylcholine receptor localization and its use as a tool in the study of cellular immuninty in myasthenia gravis.
    Conti-Tronconi B; Morgutti M; Gotti C; Clementi F
    Adv Cytopharmacol; 1979; 3():255-67. PubMed ID: 382788
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immune response to acetylcholine receptor in myasthenia gravis: II. Thymectomy and corticosteroids.
    Morgutti M; Conti-Tronconi BM; Sghirlanzoni A; Clementi F
    Neurology; 1979 May; 29(5):734-8. PubMed ID: 571572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
    Schönbeck S; Chrestel S; Hohlfeld R
    Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis, the acetylcholine receptor and the immune response.
    Barkas T
    Int J Immunopharmacol; 1979; 1(4):263-71. PubMed ID: 162144
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular and humoral immunity to acetylcholine receptor in myasthenia gravis.
    Conti Tronconi BM; Scotti A; Brigonzi A; Sher E; Fumagalli G; Peluchetti D; Clementi F
    Ital J Neurol Sci; 1982 Mar; 3(1):17-23. PubMed ID: 6979528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.
    Abramsky O; Aharonov A; Webb C; Fuchs S
    Clin Exp Immunol; 1975 Jan; 19(1):11-6. PubMed ID: 1239345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes.
    Richman DP; Patrick J; Arnason BG
    N Engl J Med; 1976 Mar; 294(13):694-8. PubMed ID: 129705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of acetylcholine receptor in diaphragms of rats with experimental autoimmune myasthenia gravis.
    Merlie JP; Heinemann S; Einarson B; Lindstrom JM
    J Biol Chem; 1979 Jul; 254(14):6328-32. PubMed ID: 447717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
    Fontana A; Fulpius BW; Cuénoud S
    Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis and acetylcholine receptor. Effect of steroids in clinical course and cellular immune response to acetylcholine receptor.
    Abramsky O; Aharonov A; Teitelbaum D; Fuchs S
    Arch Neurol; 1975 Oct; 32(10):684-7. PubMed ID: 1180731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
    Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
    Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis.
    Zurn AD; Fulpius BW
    Eur J Immunol; 1977 Aug; 7(8):529-32. PubMed ID: 902680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic site.
    Richman DP; Antel JP; Patrick JW; Arnason BG
    Neurology; 1979 Mar; 29(3):291-6. PubMed ID: 571972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental rabbit model of myasthenia gravis produced with acetylcholine receptor of nicotinic type from the "generating organ" of electric ray (author's transl)].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):16-8. PubMed ID: 7307781
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of acetylcholine receptor antibody in relatives of myasthenic patients.
    Walker GL; Nicholson LV; Mastaglia FL
    Lancet; 1980 Apr; 1(8171):778-9. PubMed ID: 6103204
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulation of lymphocytes by cholinergic receptor in myasthenia gravis.
    Conti-Tronconi BM; Di Padova F; Morgutti M; Missiroli A; Frattola L
    J Neuropathol Exp Neurol; 1977 Jan; 36(1):157-68. PubMed ID: 833615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.